Skip to main content

KEP: Cancer Epidemiology Group

We aim to improve the understanding of determinants of risk and prognosis of cancer, with a special focus on malignant lymphomas and cancers arising after organ transplantation, as well as to characterize issues of cancer survivorship. The overall goal is to provide a better basis for primary prevention of cancer, prediction of risk and prognosis, and cancer rehabilitation.

Cancer epidemiology group


What we do

Our research is mainly based on linkages of population-based health register data, often enriched with clinical data from national cancer quality registers. Our research includes several forms of cancer, although the main focus in recent years has been on various subtypes of lymphoma. Within this setting we aim to improve understanding different aspects of cancer patient survival and survivorship. The latter involves studying, for example, late adverse effects from treatment (such as risk for secondary malignancies or heart disease) or child birth potential after cancer treatment. 

We collaborate closely other research groups at KEP, other units at the Karolinska Institutet (CCK, MEB, IMM), researchers at other Swedish Universities (Uppsala, Lund), as well as internationally within the Nordic countries (the Nordic lymphoma group) and within the InterLymph consortium.


Recent Publications

Lymphoma and Myeloma

Colorectal and Prostate Cancer

Research Group Members